🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

UPDATE 1-ChemChina taps JPMorgan for Dow unit bid -sources

Published 06/22/2009, 07:28 AM
Updated 06/22/2009, 07:33 AM
DOW
-

* Dow AgroSciences unit booked $4.5 billion in sales in 2008

* Stage of bidding process still unclear

(Adds detail, background)

By Joseph Chaney

HONG KONG, June 22 (Reuters) - China National Chemical Corp (ChemChina), China's leading chemical producer, has retained JPMorgan to advise it on a bid for Dow Chemical's agrosciences unit, sources said on Monday.

Dow AgroSciences -- which sells crop protection chemicals such as herbicides and insecticides -- booked 2008 sales of $4.5 billion, according to the company's website. The unit could be sold for as much as $7 billion, analysts said.

Dow Chemical, the largest U.S. chemicals maker, is selling assets to to help pay a $9.2 billion bridge loan talen out to buy chemical company Rohm & Haas Corp in April.

Like other chemicals makers, Dow has been suffering from the economic recession and has already sold Rohm's Morton Salt unit for $1.7 billion and is evaluating options for other businesses in its portfolio.

It is unclear if the bidding process for the agrosciences unit is at a preliminary or advanced stage.

In March, Dow Chemical chief executive Andrew Liveris told Reuters the company would not be forced into selling assets on the cheap. "We've designed a structure where we can control our own destiny, rather than be forced to fire-sale," Liveris said at the time.

"More critically, we can retain very key assets like Dow AgroSciences and Dow Corning," said Liveris, adding Dow would consider selling a stake in Dow AgroSciences business if there were strategic benefits from the deal.

JPMorgan declined to comment. ChemChina was not immediately available for comment.

The sources declined to be named because they were not authorised to speak publicly about the matter.

In late February, media reports said private equity giants Blackstone and Kohlberg Kravis Roberts & Co were in early-stage discussions about taking a multibillion-dollar minority stake in the division. (Reporting by Joseph Chaney; Editing by Dan Lalor)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.